Not taking personal responsibility. Some may argue he couldn't do an RCT because the fda wouldn't let him due to potency issues.
But at the end of the day, despite this, he resubmitted the BLA and constantly talked about how confident he was it would be successful.
Now he says it's Aussie's misunderstanding of biotech, and over-exuberance.
That's disgusting
Ann: Update on BLA for Graft Versus Host Disease, page-585
-
- There are more pages in this discussion • 433 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.020(1.83%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $2.722M | 2.474M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 24632 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 25562 | 13 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |